Method for treating ischemic tissue

Details Method for treating ischemic tissue Method for treating ischemic tissue

1995-10-20

2000-09-19

Chambers, Jasemine

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

435455, 4353201, 435 691, 435 697, 435 698, A01N 4304, A61K 3170, C12N 1563, C12N 1500

Patent

active

061212466

ABSTRACT:
The present invention provides a method for treating ischemic tissue in a mammal which comprises injecting said tissue with an effective amount of a nucleic acid capable of expressing an angiogenic protein. The method of the present invention may be used to treat any ischemic tissue, i.e., a tissue having a deficiency in blood as the result of an ischemic disease. Such tissues can include, for example, muscle, brain, kidney and lung. Ischemic diseases include, for example, cerebrovascular ischemia, renal ischemia, pulmonary ischemia, limb ischemia, ischemic cardiomyopathy and myocardial ischemia.

REFERENCES:
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5661133 (1997-08-01), Leiden et al.
patent: 5693622 (1997-12-01), Wolff et al.
patent: 5792453 (1998-08-01), Hammond et al.
Baumgartner I. et al. "Constitutive expression of phVEGF.sub.165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia", Circulation 97: 1114-1123 (1998).
Friesel, R. E. et al. "Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction", FASEB J. 9: 919-925 (1995).
Henry, T. D. et al. "Double blind, placebo controlled trial of recombinant human vascular enothelial growth factor--the VIVA trial", J. Am. Coll. Cardiol. 874-4 (1999).
Young, E. "No significant differences between VEGF, placebo", Cardiology Today, Apr. 1999.
Isner, J. M. et al. "Clinical evidence of angiogenesis after arterial gene transfer of phVEGF.sub.165 in patient with ischaemic limb", The Lancet 438: 370-374 (1996).
Jiao, S. et al. "Direct gene transfer into nonhuman primate myofibers in vivo", Hum. Gene Ther. 3: 21-33 (1992).
Marshall, D. J. et al. "Recent advances in skeletal-muscle-based gene therapy", Curr. Opin. Gen. Dev. 8: 360-365 (1998).
Nabel, E. G. et al. "Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo", Nature 342: 844-846 (1993).
Jaye, M. et al. "Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells", EMBO J. 7:963-969 (1988).
Sambrook, J. et al. "Molecular Cloning, A Laboratory Manual", Cold Spring Harbor Laboratory Press, 1989, pp. 17.31-17.33.
Minchenko et al., Laboratory Investigation, vol. 71, No. 3, pp. 374-379, Sep. 1994.
Feldman et al., Fundam. Clin. Pharmacol., vol. 9, pp. 8-16, 1995.
Simons & Ware, Nature Medicine, vol. 2, pp. 519-520, May 1996.
Isner et al., Circulation, vol. 91, pp. 2687-2692, 19
Mulligan, Science, vol. 260, pp. 926-930, May
Afione et al., Clin. Pharmacokinet., vol. 28, pp. 181-189, 1995.
Riessen & Isner, Journal Am. Coll. Cardiol., vol. 23, pp. 1234-1244, 1994.
Marshall, Science, vol. 269, pp. 1050-1055, Aug. 25, 1995.
Coghlan, Focus, vol. 145, pp. 14-15, Nov. 25, 1995.
Brown, The Washington Post, "News Media Researchers `Oversold` Gene Therapy . . . Says", Dec. 8, 1995.
Setoguchi et al., Blood, vol. 84, pp. 2946-2953, Nov. 1, 1994.
Nabel et al., Nature, vol. 362, pp. 844-846, Apr. 29, 1993.
Symes et al., Current Opinion in Lipidology, vol. 5, pp. 305-312, Aug. 1994.
Hockel, et al., Arch. Surg., vol. 128 pp. 423-429 (1993).
Baffour, et al., J. Vasc. Surg., 16:181-91, 1992.
Pu, et al., J. Surg. Res., 54:575-83, 1993.
Takeshita, et al., J. Clin. Invest., 93:662-70, 1994.
Jorgensen, et al., Lancet, 1:1106-1108, 1989.
Wolinsky, et al., J. Am. Coll. Cardio., 15:475-485, 1990.
Isner, et al., Circulation, 88:1534-1557, 1993.
Wolff, et al., Science, 247:1465-1468, 1990.
Miller, Nature, 357:455-60, 1992.
Folkman, et al., Science, 235:442-447, 1987.
Klagsbrun, et al., Annu. Rev. Physiol., 53:217-239, 1991.
Folkman, et al., J. Biol. Chem.,267:10931-10934, 1992.
Symes, et al., Current Opinion in Lipidology, 5:305-312, 1994.
Pu, et al., Circulation, 88:208-215, 1993.
Ferrara, et al., Biochem. Biophys. Res. Commun., 161:851-855, 1989.
Keck, et al., Science, 246:1309-1342, 1989.
Connolly, et al., J. Biol. Chem., 264:20017-20024, 1989.
Conn, et al., Proc. Natl. Acad. Sci., USA, 87:1323-1327, 1990.
Shen, et al., Blood, 81:2767-2773, 1993.
Clauss, et al., J. Exp. Med., 172:1535-1545, 1990.
Connolly, et al., J. Clin. Invest., 84:1470-1478, 1989.
Nabel, et al., Nature, 362:844, 1993.
Davis, et al., Hum. Gene Ther., 4:151, 1993.
Wolff, et al., Biotechniques, vol. 11, No. 4 474-485, 1991.
Acsadi, et al., The New Biologist, vol. 3, No. 1, 71-81, 1991.
J. Isner and L. Feldman, The Lancet, vol. 344 (1994), pp. 1653-1654.
R. Sanders Williams, Amer. J. of Med. Sci., vol. 306, No. 2 (1993) pp. 129-136.
Mesri, et al., Cir. Res., vol. 76, No. 2 (1995), pp. 161-167.
Fan, et al., TiPS, vol. 16 (1995) pp. 57-66.
Isner, et al., Circulation, vol. 91, No. 11 (1995), pp. 2687-2692.
Supplement to Circulation, vol. 88, No. 4, Part 2 (1993) Abstracts from the 66th Scientific Sessions (pp. I-475-I476.
Capogrossi, M.C, "Gene Therapy of Coronary Artery Disease" Grant Abstract AG00811-01 (1994).
Capogrossi, M.C, "Gene Therapy of Coronary Artery Disease" Grant Abstract AG00811-02 (1995).
Isner, J.M., "Therapeutic Angiogenesis in Vascular Medicine" Grant Abstract HL-53354-01 (1995).

Affiliated with

Also associated with

Rating

Method for treating ischemic tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating ischemic tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating ischemic tissue will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1073323